Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Nature Biotechnology's academic spinouts of 2014

Nature Biotechnology volume 33, pages 247–255 (2015)Cite this article

Subjects

Ventures focusing on drug testing or therapies against rare disease, cancer, gastrointestinal disease, fibrosis and pain are among those selected by the editors in 2014's crop of startups.

In 2014, the biotech sector posted the largest ever influx of private funding since Nature Biotechnology was founded—a total of $9 billion, up 50% from the previous year. At the same time, the past two years have seen more exits through initial public offerings (IPOs) and trade sales than any other two-year period. Eyepopping valuations totaling over $100 million have been obtained for several firms with preclinical stage technology. What were the cutting-edge biotech ventures that raised venture funding during this bumper year?

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Author information

Authors and Affiliations

  1. Aaron Bouchie is a freelance writer based in Ithaca, New York.,

    Aaron Bouchie

  2. Laura DeFrancesco is Senior Editor, Nature Biotechnology.,

    Laura DeFrancesco

Authors
  1. Aaron Bouchie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura DeFrancesco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bouchie, A., DeFrancesco, L. Nature Biotechnology's academic spinouts of 2014. Nat Biotechnol 33, 247–255 (2015). https://doi.org/10.1038/nbt.3163

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3163

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing